X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER RESEARCH

期刊標題檢索 CANCER RES 最新評論: Hello, I would like to ask if all the data in this magazine requires t... (2024-10-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER RESEARCH]您好,您是該頁面的第 312133 位訪客。

期刊簡介
期刊名稱CANCER RESEARCH CANCER RESEARCH
LetPub Score
9.3
53 ratings
Rate

Reputation
10.0

Influence
8.8

Speed
9.2

期刊簡稱CANCER RES
ISSN0008-5472
E-ISSN1538-7445
h-index411
CiteScore
CiteScoreSJRSNIPCiteScore Rank
16.103.4681.509
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q131 / 404
Category: Medicine
Subcategory: Cancer Research
Q123 / 230

自引率 (2023-2024)0.80%自引率趨勢
掲載範囲
Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
官方網站http://cancerres.aacrjournals.org/
在線稿件提交http://can.msubmit.net/cgi-bin/main.plex
開放訪問No
出版商American Association for Cancer Research Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月2回刊行
創刊年1941
每年文章數273每年文章數趨勢
黃金OA百分比27.89%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ120/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-5472%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2.5 Month(s)
競爭力 *來自作者的數據: About 30%
參考鏈接
相關期刊 【CANCER RESEARCH】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330999
    BMC CANCER245505
    Asian Pacific Journal of Cancer Prevention219224
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191631
    CLINICAL CANCER RESEARCH181667
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176423
    ONCOLOGY REPORTS175031
    CA-A CANCER JOURNAL FOR CLINICIANS163632
    CANCER148385
  •  

    CANCER RESEARCH CANCER RESEARCH
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/16)
  [CANCER RESEARCH] 的評論撰寫評論
作者: 日光星宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 15:57:50 評論於
Hello, I would like to ask if all the data in this magazine requires the original data to be repeated three times?
(0) 讚! | 日光星宇

作者: YYYJSSLL


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-21 20:49:50 評論於
Hello, I wanted to ask which two senior editors were chosen for the submission. It seems like our directions are quite similar.
(0) 讚! | YYYJSSLL

作者: 火焰成周


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-27 11:06:45 評論於
My newly submitted version was deleted, leaving only the old version. I don't know why this formatting operation was done.
(0) 讚! | 火焰成周

作者: 北国升荣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-19 10:07:35 評論於
How are you doing?
(0) 讚! | 北国升荣

作者: 北风圣恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-13 10:03:06 評論於
Research focus: Experience sharing in tumor research. The first revision was mainly about formatting issues. After making adjustments and resubmitting, the manuscript has been stuck in the initial peer review process for several days. I am worried. Has anyone experienced a similar situation?
(0) 讚! | 北风圣恩

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-15 15:33:27 評論於
It usually takes several days to a few weeks to check the status of the submission.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-15 08:35:42 評論於
If the editor or reviewer suggests formatting changes, please make the revisions and re-upload the manuscript. In general, revised manuscripts do not receive a new submission date, as the original submission date is used to ensure priority and processing order.
(0) 讚! | Adelaide Lawson

作者: 红贝小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-13 19:07:48 評論於
Hello, may I ask if there will be a new submission date after re-uploading the modified format, or will it remain the same as the original date?
(0) 讚! | 红贝小郎君

作者: 江南乐儿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-13 09:08:08 評論於
The amount of posts has decreased.
(0) 讚! | 江南乐儿

作者: 无妄鸿振


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 22:39:20 評論於
Thank you, it took me about 3 weeks to revise the first draft. Currently, it has been in UEC status for 5 days, so I will wait a little longer.
(0) 讚! | 无妄鸿振

作者: 冬马培芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 11:04:33 評論於
To show appreciation for the help from fellow users, here is a simple list of the submission to acceptance process and experience:

First Submission:
- Revision Received 2024-y-16 07:38:47
- Waiting for Revision 2023-x+1-28 16:11:34
- Decision Sent to Author 2023-x+1-28 16:11:34
- Under Editorial Consideration 2023-x+1-26 17:54:28
- Under Review 2023-x-27 15:45:07
- At this point, the designated corresponding author will receive an email informing them that the manuscript has been sent out for external review. The email also states that the external review process for initial submissions takes 3-4 weeks and 1-2 weeks for revised manuscripts.
- Under Editorial Consideration 2023-x-20 08:32:22
- Initial QC 2023-x-18 11:25:49
- Manuscript Submission 2023-x-18 09:45:06
- External review feedback: 1 reviewer suggested minor revisions, 1 reviewer gave high overall evaluation but provided many useful suggestions, and 1 reviewer gave neutral feedback? with reasonable suggestions, totaling 20 comments.
- First decision: Major revision, with a three-month deadline.

Second Submission:
- Revision Received 2024-y+2-06 10:09:57
- Waiting for Revision 2024-y+2-01 10:54:34
- Decision Sent to Author 2024-y+2-01 10:54:34
- Under Editorial Consideration 2024-y+1-15 16:46:46
- Under Review 2024-y-25 12:14:15
- Under Editorial Consideration 2024-y-16 07:38:51
- Manuscript Submission 2024-y-16 07:38:47
- The external review process for the second submission took longer than expected, resulting in a direct pre-acceptance.

Third Submission:
- Manuscript Ready for Publication 2024-y+2-17 15:49:20
- Decision Sent to Author 2024-y+2-15 16:09:11
- Under Editorial Consideration 2024-y+2-06 10:10:01
- Manuscript Submission 2024-y+2-04 05:31:55
- This stage mainly focuses on formatting requirements, which are quite strict and required multiple adjustments. There is a mention of the "Funding Body Archiving Mandates" requirement, where selecting the funded individual turns the option gray, and leaving it blank after submission is fine as the editors will handle it.
- Best wishes to all fellow users for success in their submissions! Good luck!
(0) 讚! | 冬马培芳

作者: 冬马培芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 08:18:59 評論於
The UR status was maintained for 3 weeks, and the UEC status was also maintained for 15 days, and then pre-approval was given.
(0) 讚! | 冬马培芳

作者: 兰兰三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-02 21:30:36 評論於
May I ask how things turned out later?
(0) 讚! | 兰兰三岁啦

作者: 无妄鸿振


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-30 14:20:29 評論於
How long does it take for the "under review" status to receive feedback after it has been revised?
(0) 讚! | 无妄鸿振

作者: 墟散沈然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-26 17:26:07 評論於
Same question, what happened afterwards?
(0) 讚! | 墟散沈然

作者: 震雷博超


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-25 21:32:31 評論於
Research focus: Tumor basic research; sharing experiences in tumors: It's not easy to increase by 1 point in 2023 when the impact factor is generally decreasing.
(0) 讚! | 震雷博超

作者: 宗室锐立


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-31 16:55:30 評論於
Okay, it has been rejected.
(0) 讚! | 宗室锐立

作者: 一只红香呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-29 20:22:36 評論於
Hello, may I ask how long it takes for a submission to be reviewed?
(0) 讚! | 一只红香呀

作者: 宗室锐立


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-28 16:55:45 評論於
Okay, it has been sent to the editor today, waiting for judgment
(0) 讚! | 宗室锐立

作者: 宗室锐立


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 21:01:09 評論於
Hello, how have you been lately?
(0) 讚! | 宗室锐立

作者: 一只红香呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 18:18:16 評論於
Possibly need under editorial consideration, just get it to the editors, but nothing has happened even after that
(0) 讚! | 一只红香呀

作者: 宗室锐立


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-24 10:10:45 評論於
Submission hit rate: 25.0 
Research focus: circRNA; ferroptosis; melanoma 
Experience sharing: Hi everyone, it has been 4 days since the initial QC, but no progress has been made. What should I do? Does this mean it has reached the editor?
(0) 讚! | 宗室锐立

作者: 一只红香呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 22:19:48 評論於
Research focus: tumor basics sharing: under editorial consideration for 11 days, when will it be submitted for review?
(0) 讚! | 一只红香呀

作者: 是你的鹏云呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 22:09:40 評論於
Awesome ?
(0) 讚! | 是你的鹏云呀

作者: 冬马培芳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 20:46:39 評論於
UEC waited for 16 days and has been pre-accepted. I will organize the submission experience when I have time and share it with everyone for reference. Hopefully, it will be helpful to everyone. Good luck!
(0) 讚! | 冬马培芳

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/16)

開始撰寫 [CANCER RESEARCH] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*